Together, these results suggest that reduced interaction of neuromuscular disease-causing TRPV4 mutants with ARHGEF10 and the resulting loss of ARHGEF10-mediated inhibition may contribute to the increased ion channel activity characteristic of these mutant channels. Here, ARHGEF10 is linked to neuromuscular disease.